1 | Naloxone (D08249) | [1] Naloxone Naloxone | [1] Naloxone
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 6 6, 226 💬 |
2 | NALOXONE HYDROCHLORIDE (D08249) | [1] Naloxone Naloxone | [1] Naloxone
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
3 | NALOXONE HYDROCHLORIDE DIHYDRATE (D08249) | [1] Naloxone Naloxone | [1] Naloxone
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
4 | Oxycodone naloxone prolonged release tablets (D08249) | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
5 | Oxycodone/naloxone prolonged release t (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
6 | Oxycodone/Naloxone Prolonged Release tablets (D08249) | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
7 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
8 | Oxycodone/naloxone prolonged release tablets 10/5 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
9 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
10 | Oxycodone/naloxone prolonged release tablets 20/10 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
11 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
12 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg (D08249) | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
(D08249) 💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |